Efficacy of the Modified 5-Item Frailty Index in Predicting Surgical-Site Infections in Patients Undergoing Breast Implant Augmentation: A National Surgical Quality Improvement Project-Based 5-Year Study.

Aesthetic surgery journal. Open forum 2023 Vol.5() p. ojad067

Liu H, Akhavan A, Yin R, Ibelli T, Mandelbaum M, Katz A, Etigunta S, Alerte E, Kuruvilla A, Liu C, Taub PJ

관련 도메인

Abstract

[BACKGROUND] The ability to predict breast implant augmentation complications can significantly inform patient management. A frailty measure, such as the modified 5-item frailty index (mFI-5), is becoming an increasingly established risk factor for adverse postoperative outcomes. The authors hypothesized that the mFI-5 is predictive of 30-day postoperative complications in breast augmentation.

[OBJECTIVES] To investigate if mFI-5 can predict the likelihood and magnitude of 30-day complications resulting from breast augmentations.

[METHODS] A retrospective review study of the National Surgical Quality Improvement Program database for patients who underwent breast implant augmentation without other concurrent procedures, from 2015 to 2019. Age, BMI, number of major comorbidities, American Society of Anesthesiologists (ASA) classifications, smoking status, mFI-5 score, and modified Charlson comorbidity index score were compared as predictors of all-cause 30-day complications and 30-day surgical-site complications using regression analyses.

[RESULTS] Overall, 2478 patients were analyzed, and among them, 53 patients developed complications (2.14%). mFI-5 score significantly predicted surgical-site infection (SSI) complications (odds ratio [OR] = 4.24, = .026). Frail patients had a higher occurrence of SSIs than nonfrail patients ( = .049). Multivariable analyses showed ASA class predicted 30-day SSI complications (OR = 5.77, = .027) and mFI-5 approached, but did not reach full significance in predicting overall 30-day complications (OR = 3.14, = .085).

[CONCLUSIONS] To date, the impact of frailty on breast implant procedure outcomes has not been studied. Our analysis demonstrates that the mFI-5 is a significant predictor for SSIs in breast implant augmentation surgery and is associated with overall complications. By preoperatively identifying frail patients, the surgical team can better account for postoperative support to minimize the risk of complications.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 7
합병증 ssi 감염 dict 2
시술 breast augmentation 유방성형술 dict 1
합병증 infection 감염 dict 1
합병증 breast implant scispacy 1
약물 ASA → American Society of Anesthesiologists C2346733
American Society of Anesthesiologists
scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 Frailty C0424594
Frailty
scispacy 1
질환 breast implant C0178391
breast implant procedure
scispacy 1
질환 comorbidity C0009488
Comorbidity
scispacy 1
질환 surgical-site scispacy 1
질환 Frail C0871754
Frail
scispacy 1
질환 SSIs scispacy 1
질환 breast implant procedure scispacy 1
기타 Patients scispacy 1
기타 patient scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문